Filed: 11/1/2022ACC: 0001104659-22-113331
📋 What this filing means
TEKLA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 168 equity positions with a total reported market value of $2.44M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
168
Positions
$2.44M
Total AUM (reported)
38.50M
Total Shares
Allocation by class
COMMON$2.16M88.6%
SPONSORED ADR$142.7K5.8%
SHARES$74.0K3.0%
CLASS A$20.3K0.8%
SPONSORED ADS$17.3K0.7%
S&P BIOTECH ETF$11.7K0.5%
NAMEN AKT$3.6K0.1%
Portfolio Concentration
Top 3$383.4K15.7%
4–10$560.8K23.0%
11–25$668.5K27.4%
Rest$830.0K34.0%
Top 3 weight
15.7%
Top 10 weight
38.7%
Voting Authority Distribution
Total shares with voting rights: 38.50M
Sole
Full voting authority
38.50M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole168
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings168
Rows:
Unitedhealth Group Inc.
SOLEShares274.05K
TypeSH
Market value$138.4K
5.67%
Sole
274.05K
Shared
0.00
None
0.00
Johnson & Johnson
SOLEShares783.78K
TypeSH
Market value$128.0K
5.24%
Sole
783.78K
Shared
0.00
None
0.00
Amgen Inc.
SOLEShares518.87K
TypeSH
Market value$117.0K
4.79%
Sole
518.87K
Shared
0.00
None
0.00
Gilead Sciences, Inc.
SOLEShares1.62M
TypeSH
Market value$100.1K
4.10%
Sole
1.62M
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc.
SOLEShares313.40K
TypeSH
Market value$90.7K
3.71%
Sole
313.40K
Shared
0.00
None
0.00
Eli Lilly and Company
SOLEShares240.58K
TypeSH
Market value$77.8K
3.18%
Sole
240.58K
Shared
0.00
None
0.00
Abbott Laboratories
SOLEShares791.05K
TypeSH
Market value$76.5K
3.13%
Sole
791.05K
Shared
0.00
None
0.00
Regeneron Pharmaceuticals, Inc.
SOLEShares109.06K
TypeSH
Market value$75.1K
3.08%
Sole
109.06K
Shared
0.00
None
0.00
AbbVie Inc.
SOLEShares526.84K
TypeSH
Market value$70.7K
2.89%
Sole
526.84K
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares1.27M
TypeSH
Market value$69.8K
2.86%
Sole
1.27M
Shared
0.00
None
0.00
Bristol-Myers Squibb Company
SOLEShares879.48K
TypeSH
Market value$62.5K
2.56%
Sole
879.48K
Shared
0.00
None
0.00
Cigna Corp.
SOLEShares210.73K
TypeSH
Market value$58.5K
2.39%
Sole
210.73K
Shared
0.00
None
0.00
Illumina, Inc.
SOLEShares294.94K
TypeSH
Market value$56.3K
2.30%
Sole
294.94K
Shared
0.00
None
0.00
Humana Inc.
SOLEShares113K
TypeSH
Market value$54.8K
2.24%
Sole
113K
Shared
0.00
None
0.00
Pfizer Inc.
SOLEShares1.13M
TypeSH
Market value$49.5K
2.03%
Sole
1.13M
Shared
0.00
None
0.00
Merck & Co., Inc.
SOLEShares552.12K
TypeSH
Market value$47.5K
1.95%
Sole
552.12K
Shared
0.00
None
0.00
Thermo Fisher Scientific Inc.
SOLEShares93.70K
TypeSH
Market value$47.5K
1.95%
Sole
93.70K
Shared
0.00
None
0.00
Horizon Therapeutics plc
SOLEShares734.35K
TypeSH
Market value$45.4K
1.86%
Sole
734.35K
Shared
0.00
None
0.00
Molina Healthcare, Inc.
SOLEShares119.53K
TypeSH
Market value$39.4K
1.61%
Sole
119.53K
Shared
0.00
None
0.00
Stryker Corp.
SOLEShares193.53K
TypeSH
Market value$39.2K
1.60%
Sole
193.53K
Shared
0.00
None
0.00
Biogen Inc.
SOLEShares145.44K
TypeSH
Market value$38.8K
1.59%
Sole
145.44K
Shared
0.00
None
0.00
Moderna, Inc.
SOLEShares314.92K
TypeSH
Market value$37.2K
1.52%
Sole
314.92K
Shared
0.00
None
0.00
Danaher Corp.
SOLEShares124.56K
TypeSH
Market value$32.2K
1.32%
Sole
124.56K
Shared
0.00
None
0.00
Boston Scientific Corp.
SOLEShares795.22K
TypeSH
Market value$30.8K
1.26%
Sole
795.22K
Shared
0.00
None
0.00
Alnylam Pharmaceuticals, Inc.
SOLEShares143.21K
TypeSH
Market value$28.7K
1.17%
Sole
143.21K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Unitedhealth Group Inc.SOLE | Common | 274.05K | SH | $138.4K 5.67% | 274.05K | 0.00 | 0.00 |
Johnson & JohnsonSOLE | Common | 783.78K | SH | $128.0K 5.24% | 783.78K | 0.00 | 0.00 |
Amgen Inc.SOLE | Common | 518.87K | SH | $117.0K 4.79% | 518.87K | 0.00 | 0.00 |
Gilead Sciences, Inc.SOLE | Common | 1.62M | SH | $100.1K 4.10% | 1.62M | 0.00 | 0.00 |
Vertex Pharmaceuticals Inc.SOLE | Common | 313.40K | SH | $90.7K 3.71% | 313.40K | 0.00 | 0.00 |
Eli Lilly and CompanySOLE | Common | 240.58K | SH | $77.8K 3.18% | 240.58K | 0.00 | 0.00 |
Abbott LaboratoriesSOLE | Common | 791.05K | SH | $76.5K 3.13% | 791.05K | 0.00 | 0.00 |
Regeneron Pharmaceuticals, Inc.SOLE | Common | 109.06K | SH | $75.1K 3.08% | 109.06K | 0.00 | 0.00 |
AbbVie Inc.SOLE | Common | 526.84K | SH | $70.7K 2.89% | 526.84K | 0.00 | 0.00 |
AstraZeneca PLCSOLE | Sponsored ADR | 1.27M | SH | $69.8K 2.86% | 1.27M | 0.00 | 0.00 |
Bristol-Myers Squibb CompanySOLE | Common | 879.48K | SH | $62.5K 2.56% | 879.48K | 0.00 | 0.00 |
Cigna Corp.SOLE | Common | 210.73K | SH | $58.5K 2.39% | 210.73K | 0.00 | 0.00 |
Illumina, Inc.SOLE | Common | 294.94K | SH | $56.3K 2.30% | 294.94K | 0.00 | 0.00 |
Humana Inc.SOLE | Common | 113K | SH | $54.8K 2.24% | 113K | 0.00 | 0.00 |
Pfizer Inc.SOLE | Common | 1.13M | SH | $49.5K 2.03% | 1.13M | 0.00 | 0.00 |
Merck & Co., Inc.SOLE | Common | 552.12K | SH | $47.5K 1.95% | 552.12K | 0.00 | 0.00 |
Thermo Fisher Scientific Inc.SOLE | Common | 93.70K | SH | $47.5K 1.95% | 93.70K | 0.00 | 0.00 |
Horizon Therapeutics plcSOLE | Common | 734.35K | SH | $45.4K 1.86% | 734.35K | 0.00 | 0.00 |
Molina Healthcare, Inc.SOLE | Common | 119.53K | SH | $39.4K 1.61% | 119.53K | 0.00 | 0.00 |
Stryker Corp.SOLE | Common | 193.53K | SH | $39.2K 1.60% | 193.53K | 0.00 | 0.00 |
Biogen Inc.SOLE | Common | 145.44K | SH | $38.8K 1.59% | 145.44K | 0.00 | 0.00 |
Moderna, Inc.SOLE | Common | 314.92K | SH | $37.2K 1.52% | 314.92K | 0.00 | 0.00 |
Danaher Corp.SOLE | Common | 124.56K | SH | $32.2K 1.32% | 124.56K | 0.00 | 0.00 |
Boston Scientific Corp.SOLE | Common | 795.22K | SH | $30.8K 1.26% | 795.22K | 0.00 | 0.00 |
Alnylam Pharmaceuticals, Inc.SOLE | Common | 143.21K | SH | $28.7K 1.17% | 143.21K | 0.00 | 0.00 |
Page 1 of 7
…